Pak‐Leong Lim

658 citations
27 papers · 512 indexed · h-index 11
Topics
Monoclonal and Polyclonal Antibodies Research (12 papers)T-cell and B-cell Immunology (8 papers)Salmonella and Campylobacter epidemiology (5 papers)

In The Last Decade

Pak‐Leong Lim

27 papers receiving 494 citations

Peers

Pak‐Leong Lim
Comparison fields: 5 of 84
  • Molecular Biology 272
  • Infectious Diseases 122
  • Food Science 99
  • Immunology 85
  • Radiology, Nuclear Medicine and Imaging 81
Replace Ivano Arioli with:
Ivano Arioli Italy
Djenet Bousbaine United States
Sarah Jezzard United Kingdom
Kaori Denda‐Nagai Japan
Elena Cartocci Italy
William D. Perkins United States
J.M. Tournier France
Siba Prasad Bhattacharyya United States
Kanna Kobayashi Japan
Eva M. Click United States
Pak‐Leong Lim relative to Ivano Arioli Italy Ivano Arioli's profile →
Citations per field
00.5×2.9×
Ivano Arioli · 1×
Citations per year

Countries citing papers authored by Pak‐Leong Lim

Since Specialization
Citations

This map shows the geographic impact of Pak‐Leong Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pak‐Leong Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pak‐Leong Lim more than expected).

Fields of papers citing papers by Pak‐Leong Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pak‐Leong Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pak‐Leong Lim. The network helps show where Pak‐Leong Lim may publish in the future.

Co-authorship network of co-authors of Pak‐Leong Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Pak‐Leong Lim. A scholar is included among the top collaborators of Pak‐Leong Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pak‐Leong Lim. Pak‐Leong Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 1
3 2
4 29
5 27
6 24
7 16
8 9
9 6
10 46
11 7
12 22
13 143
14 7
15 8
16 1
17 4
18 8
19 2
20 6

About Pak‐Leong Lim

Pak‐Leong Lim is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology, having authored 27 papers that have together received 512 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), T-cell and B-cell Immunology (8 papers) and Salmonella and Campylobacter epidemiology (5 papers). The work is most often cited by research in Endocrinology (63 citations), Infectious Diseases (122 citations) and Food Science (99 citations). Pak‐Leong Lim has collaborated with scholars based in Hong Kong, China and United States. Frequent co-authors include Frankie C. H. Tam, Yiu‐Loon Chui, M Jegathesan, Sui-Fan Tong, Frank McCormick, Ka‐Fai To, Ho‐Keung Ng, Moncef Zouali, Stephanie Chow and KK Lee. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026